BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36786841)

  • 1. Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
    Keck MK; Sill M; Wittmann A; Joshi P; Stichel D; Beck P; Okonechnikow K; Sievers P; Wefers AK; Roncaroli F; Avula S; McCabe MG; Hayden JT; Wesseling P; Øra I; Nistér M; Kranendonk MEG; Tops BBJ; Zapotocky M; Zamecnik J; Vasiljevic A; Fenouil T; Meyronet D; von Hoff K; Schüller U; Loiseau H; Figarella-Branger D; Kramm CM; Sturm D; Scheie D; Rauramaa T; Pesola J; Gojo J; Haberler C; Brandner S; Jacques T; Sexton Oates A; Saffery R; Koscielniak E; Baker SJ; Yip S; Snuderl M; Ud Din N; Samuel D; Schramm K; Blattner-Johnson M; Selt F; Ecker J; Milde T; von Deimling A; Korshunov A; Perry A; Pfister SM; Sahm F; Solomon DA; Jones DTW
    Acta Neuropathol; 2023 Apr; 145(4):511-514. PubMed ID: 36786841
    [No Abstract]   [Full Text] [Related]  

  • 2. Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
    Keck MK; Sill M; Wittmann A; Joshi P; Stichel D; Beck P; Okonechnikow K; Sievers P; Wefers AK; Roncaroli F; Avula S; McCabe MG; Hayden JT; Wesseling P; Øra I; Nistér M; Kranendonk MEG; Tops BBJ; Zapotocky M; Zamecnik J; Vasiljevic A; Fenouil T; Meyronet D; von Hoff K; Schüller U; Loiseau H; Figarella-Branger D; Kramm CM; Sturm D; Scheie D; Rauramaa T; Pesola J; Gojo J; Haberler C; Brandner S; Jacques T; Sexton Oates A; Saffery R; Koscielniak E; Baker SJ; Yip S; Snuderl M; Ud Din N; Samuel D; Schramm K; Blattner-Johnson M; Selt F; Ecker J; Milde T; von Deimling A; Korshunov A; Perry A; Pfister SM; Sahm F; Solomon DA; Jones DTW
    Acta Neuropathol; 2023 Jan; 145(1):49-69. PubMed ID: 36437415
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Adnani L; Dixit R; Chen X; Balakrishnan A; Modi H; Touahri Y; Logan C; Schuurmans C
    Biol Open; 2018 Nov; 7(11):. PubMed ID: 30361413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities.
    Hensen K; Van Valckenborgh IC; Kas K; Van de Ven WJ; Voz ML
    Cancer Res; 2002 Mar; 62(5):1510-7. PubMed ID: 11888928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and embryonic expression of zebrafish PLAG genes.
    Pendeville H; Peers B; Kas K; Voz ML
    Gene Expr Patterns; 2006 Mar; 6(3):267-76. PubMed ID: 16378757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins.
    Kas K; Voz ML; Hensen K; Meyen E; Van de Ven WJ
    J Biol Chem; 1998 Sep; 273(36):23026-32. PubMed ID: 9722527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.
    Wezensky SJ; Hanks TS; Wilkison MJ; Ammons MC; Siemsen DW; Gauss KA
    Gene; 2010 Feb; 452(1):22-34. PubMed ID: 20025940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology.
    Alturkustani M; Walker AD; Tran I; Snuderl M; Cotter JA
    Pathol Int; 2022 Aug; 72(8):402-410. PubMed ID: 35763016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
    Guo J; Wang M; Wang Z; Liu X
    PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumoylation and acetylation play opposite roles in the transactivation of PLAG1 and PLAGL2.
    Zheng G; Yang YC
    J Biol Chem; 2005 Dec; 280(49):40773-81. PubMed ID: 16207715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLAGL2 regulates actin cytoskeletal architecture and cell migration.
    Sekiya R; Maeda M; Yuan H; Asano E; Hyodo T; Hasegawa H; Ito S; Shibata K; Hamaguchi M; Kikkawa F; Kajiyama H; Senga T
    Carcinogenesis; 2014 Sep; 35(9):1993-2001. PubMed ID: 24675530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines.
    Furukawa T; Adachi Y; Fujisawa J; Kambe T; Yamaguchi-Iwai Y; Sasaki R; Kuwahara J; Ikehara S; Tokunaga R; Taketani S
    Oncogene; 2001 Aug; 20(34):4718-27. PubMed ID: 11498794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1.
    Wu L; Zhao N; Zhou Z; Chen J; Han S; Zhang X; Bao H; Yuan W; Shu X
    Theranostics; 2021; 11(2):700-714. PubMed ID: 33391500
    [No Abstract]   [Full Text] [Related]  

  • 15. Tip60 modulates PLAGL2-mediated transactivation by acetylation.
    Ning J; Zheng G; Yang YC
    J Cell Biochem; 2008 Feb; 103(3):730-9. PubMed ID: 17551969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).
    Van Dyck F; Declercq J; Braem CV; Van de Ven WJ
    Int J Oncol; 2007 Apr; 30(4):765-74. PubMed ID: 17332914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLAGL2 Promotes the Proliferation and Migration of Diffuse Large B-cell Lymphoma Cells via Wnt/β-catenin Pathway.
    Jin W; Wang X
    Ann Clin Lab Sci; 2022 May; 52(3):359-366. PubMed ID: 35777795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
    Abdollahi A
    J Cell Physiol; 2007 Jan; 210(1):16-25. PubMed ID: 17063461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare Recurrent EWSR1-PLAGL1 Rearranged Intracranial Tumor With Biphasic Epithelioid Differentiation: One Case Report With Literature Review.
    Xing AY; Yang WW; Liu YL; Sun NN; Hao XM; Wang SX; Mu K
    Front Oncol; 2022; 12():938385. PubMed ID: 35912228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.
    Van Dyck F; Delvaux EL; Van de Ven WJ; Chavez MV
    J Biol Chem; 2004 Aug; 279(34):36121-31. PubMed ID: 15208321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.